Hypertension in adults: diagnosis and management

Supporting evidence

• Surveillance report

• November 2024 surveillance of hypertension in adults: diagnosis and management - choices of antihypertensive drugs based on ethnicity (NICE guideline NG136)

• November 2023 exceptional surveillance of blood pressure targets for adults across NICE guidelines (NICE guidelines NG17, NG136 and NG203)

• February 2023 surveillance of hypertension in adults: diagnosis and management (NICE guideline NG136) and transient loss of consciousness ('blackouts') in over 16s (NICE guideline CG109)

• Appendix A: Stakeholder consultation comments table (PDF 750 KB)

  Published:

  15 February 2023

• Evidence review

• Evidence reviews – March 2022

• J: Blood pressure targets (PDF 1.57 MB)

  Published:

  18 March 2022

• K: Pharmacological treatment in CVD (PDF 1.84 MB)

  Published:

  18 March 2022

• Evidence reviews – August 2019

• A: Diagnosis (PDF 2.38 MB)

  Published:

  28 August 2019

• B: Monitoring (PDF 2.02 MB)

  Published:

  28 August 2019

• C: Initiating treatment (PDF 1.72 MB)

  Published:

  28 August 2019

• D: Targets (PDF 1.37 MB)

  Published:

  28 August 2019

• E: Step 1 treatment (PDF 1.29 MB)

  Published:

  28 August 2019

• F: Step 2 and step 3 treatment (PDF 1.17 MB)

  Published:

  28 August 2019

• G: Step 4 treatment (PDF 1.12 MB)

  Published:

  28 August 2019

• H: Relaxation therapies (PDF 1.06 MB)

  Published:

  28 August 2019

• I: Same-day specialist review (PDF 1.57 MB)

  Published:

  28 August 2019

• Other supporting evidence

• Methods – March 2022 (PDF 635 KB)

  Published:

  18 March 2022

• Cost-effectiveness analysis: treatment initiation threshold for people with stage 1 hypertension (PDF 2.4 MB)

  Published:

  28 August 2019

• Methods – August 2019 (PDF 1014 KB)

  Published:

  28 August 2019

• Full guidance

• Full guideline – August 2011

• Full guideline (PDF 10.78 MB)

  Published:

  24 August 2011